Podcasts about imperial college london universities

"We need to find a way to hold on to the beauty and magic and wonder of these substances but we have to find a language and a mechanism to make them accessible because it´s the current situation that´s exclusive and inaccessible. It´s what I´m doing. Medicalizing is increasing accessibility and inclusivity, not reducing it."Dr Ben Sessa (MBBS BSc MRCPsych) is a consultant psychiatrist based in the UK and one of the world´s leading psychedelic drug researchers. Sessa specialises in Child and Adolescent Psychiatry with a special interest in the developmental aspects of trauma in children and how this contributes to adult mental disorder and especially substance dependence. Using this experience of child psychopathology, he carries out assessments for the family law courts and provides psychiatric care to teenagers and adults with post-trauma symptoms.Dr Sessa is currently a senior research fellow at Bristol, Cardiff and Imperial College London Universities, where he is conducting the UK’s first clinical studies with MDMA-assisted therapy for the treatment of PTSD and alcohol dependence syndrome. In the last ten years he has worked on several UK-based human pharmacology trials as study doctor or as a healthy subject administering and receiving test doses of LSD, psilocybin, MDMA and ketamine. He is the author of several dozen peer-reviewed articles in the mainstream medical press and has written two books exploring psychedelic medicine; The Psychedelic Renaissance (2012) and To Fathom Hell or Soar Angelic (2015). Dr Sessa is an outspoken lobbyist for drug reform in the UK, advocating for a more progressive policy of regulation that would reduce the harms of recreational drug use and provide increased opportunities for clinical psychedelic research. He is also co-founder and director of the Breaking Convention conference.This was an eye-opening conversation that got me thinking about the notion of inclusivity/exclusivity of psychedelic medicines and the way we can use language to assess the risk/reward factors of drug use, research and therapeutic interventions in modern society. Ben is a tremendously impassioned voice in this renaissance and a true pioneer in the way those struggling most may find assistance with psychedelic therapy.Thanks for listening and please share this and other episodes with your friends. Feel free to get in touch via email if you´d like to share your thoughts and experiences too!Follow Dr Sessa: https://twitter.com/bensessa?lang=enBen´s website: http://www.drsessa.com/Current research, clinics & training: AWAKN Life Sciences IncIntro music: https://www.akirathedon.com/Outro music: Roof: So So - Epidemic SoundListen and support the Primal Movers Podcast on the usual platformshttps://www.buzzsprout.com/276060/Primal Movers YouTube channel - Video episodeshttps://www.youtube.com/channel/UC6U50aWNy1GikYV0NLm6nBA

Dr Ben Sessa was the first doctor to administer MDMA assisted therapy in the 21st century and Christopher Trudgian was one of his very first patients. They both join Professor David Nutt to answer the question… can MDMA be used therapeutically to treat addiction and/or PTSD?The links between childhood trauma/PTSD and adult addiction are very apparent. It is now well documented that MDMA has a therapeutic potential to treat PTSD could that mean that patients suffering with PTSD-related addiction could benefit from this type of therapy? To do this, Dr. Sessa had to examine the childhood trauma, sexual abuse and the selectively impaired fear response.Dr Sessa is a consultant child and adolescent psychiatrist working in adult addiction services and with custodial detained young people in a secure adolescent setting. Dr Sessa is currently a senior research fellow at Bristol, Cardiff and Imperial College London Universities, where he is conducting the UK's first clinical studies with MDMA-assisted therapy for the treatment of PTSD and alcohol dependence syndrome. In the last ten years he has worked on several UK-based human pharmacology trials as study doctor or as a healthy subject administering and receiving test doses of LSD, psilocybin, MDMA and ketamine.Ben Sessa - www.drsessa.comWhy MDMA Therapy for Alcohol Use Disorder and Why Now? Neuropharmacology (2017) - https://www.ncbi.nlm.nih.gov/pubmed/29126911Addaction/WeAreWithYou - https://www.wearewithyou.org.uk/MDMA - https://drugscience.org.uk/drug-information/mdma/MAPS MDMA - https://maps.org/research/mdmaMDMA Assisted-therapy training - https://maps.org/trainingMisuse of Drugs Act 1971 - http://www.legislation.gov.uk/ukpga/1971/38/contentsBecome a Drug Science Community Member: https://www.donate.drugscience.org.uk/Twitter: @ProfDavidNutt @Drug_ScienceA Fascinate Productions podcast for Drug Science ★ Support this podcast ★

This time I talk to the british fun- gentleman Dr Ben Sessa. He is an approved MDMA and psilocybin psychotherapist. currently a senior research fellow at Bristol and Imperial College London Universities. He is a co-founder and director of the UK's Breaking Convention conference. Dr Sessa is becoming well known for his MDMA trials and did a TED Talk about treating child hood trauma with MDMA in 2016. Sessa thinks MDMA could be psychiatry’s antibiotic. I talk to Ben about trauma and a possible cure with MDMA. So what if after the crisis we are experiencing now in times of Covid-19 will leave a lot of people with traits of PTSD aka post traumatic stress disorder?

Dr Ben Sessa (MBBS BSc MRCPsych) is a consultant child and adolescent psychiatrist. He trained at UCL medical school, graduating in 1997, and he is interested in the developmental trajectory from child maltreatment to adult mental health disorders. Dr Sessa is an approved MDMA and psilocybin psychotherapist, currently a senior research fellow at Bristol and Imperial College London Universities, where he is conducting the UK's first clinical study with MDMA-assisted therapy for the treatment of PTSD and alcohol dependence syndrome. He is also lead therapist on Bristol-based study investigating the role for psilocybin therapy for depression. He is currently working with industry figures to set-up a network of UK-based psychedelic therapy clinics.In the last ten years he has worked on several UK-based human pharmacology trials as study doctor or as a healthy subject administering and receiving test doses of LSD, DMT, psilocybin, MDMA and ketamine. He is the author of several dozen peer-reviewed articles in the mainstream medical press and has written two books exploring psychedelic medicine; The Psychedelic Renaissance (2012 / 2017) and To Fathom Hell or Soar Angelic (2015). In speaking publicly at universities and medical conferences, Dr Sessa is outspoken on lobbying for change in the current system by which drugs are classified in the UK, believing a more progressive policy of regulation would reduce the harms of recreational drug use and provide increased opportunities for clinical psychedelic research.He is a co-founder and director of the UK's Breaking Convention conference.Ben’s website: www.drsessa.comNeed support on your medicine path?1-to-1 yoga, plant medicine integration and transformative coaching with Brian Jameshttp://brianjames.caSupport the Podcast!1. Leave a review on iTunes, or share with your friends on social media2. Become a Patreon supporter at http://patreon.com/medicinepath and gain access to podcast extras and hours of yoga practice resources including vinyasa sequences, breathwork, chanting and guided meditations.3. Leave a one-time donation at http://paypal.me/medicinepathyoga4. Purchase a print or Kindle version of my new book, Yoga & Plant Medicine: https://amzn.to/2mv3i36About Brian JamesBrian James is a yoga teacher, transformational coach and psychedelic integration counselor currently living in Montréal, Canada with his wife, astrologer Debbie Stapleton and their Boston Terrier Kingston. He has been exploring the intersection of yoga and shamanism for over 25 years.medicinepathpodcast.cominstagram.com/brianjames.medicinepathtags: brian james, ben sessa, psychedelics, psychotherapy, psychiatry, research, mdma, psilocybin, lsd, dmt, ketamine

In this episode, Kyle and Joe interview Ben Sessa, a Consultant Psychiatrist. Ben comes on the show to talk about preliminary results from the first ever, MDMA assisted therapy for alcohol use disorder (AUD). 3 Key Points: Ben Sessa plays a role in leading the current MDMA assisted therapy study for alcohol use disorder, and shares preliminary results. In the current stage, out of the first 12 patients, 2 have turned back to drinking, 5 have stayed completely dry and another 5 who have had a drink or two but have not relapsed back to their typical levels of consumption. Most people with a long term substance addiction have a history of trauma. MDMA can help people feel safe, in order to work through and heal trauma. Support the show Patreon Leave us a review on iTunes Share us with your friends – favorite podcast, etc Join our Facebook group - Psychedelics Today group – Find the others and create community. Navigating Psychedelics Trip Journal                                               Integration Workbook Show Notes Preliminary Results They had 13 people in the study, and they took data on 4 people The first caveat in these results is that there was no blinding and no placebo in this study There is no way to tell that it was solely the drug that resulted in the effects In terms of tolerability, everyone preferred it to other treatment, there were no bad reactions to the MDMA, there were no negative reactions, it was a total success in terms of tolerability In the current stage, out of the first 12 patients, 2 have turned back to drinking, 5 have stayed completely dry and another 5 who have had a drink or two but have not relapsed back to their typical levels of consumption They did a similar study previous to this one except without the MDMA and they had 11 patients, 9 of them went back to their full level of consumption They chose alcohol use disorder because it's so difficult to treat All patients are recruits from local drug and alcohol services Ben picks them up after they have detoxed, after they have been cured of the physical dependence, but when they have yet to be cured of the psychological dependence They receive 2 dosing days within their 8 week therapy (usually weeks 3 and 6) They do 125mg and then half that size dose 2 hours later, which sustains the high Ben mentions that recruitment is difficult, a lot of people have a drinking problem, but they can't have patients that are depressed, suicidal, pregnant, epileptic, etc. Future for the Study Up until next March, they are continuing to take in new patients for the study to have more data The next step is to have a randomized control study This current study is sponsored by Imperial College of London It's not a MAPS sponsored study, it's the first non MAPS, MDMA study The main papers, with all the data are over a year and a half away from publishing Addiction and Trauma “MDMA addiction is as rare as a hen with teeth.” - Ben “Most people with a long term substance addiction have a history of trauma.” - Ben Trauma and PTSD is highly treatment resistant There are certain drugs that inhibit fear response, such as alcohol, heroin, etc They make you forget the pain but you can't work with them and do therapy with them, with MDMA you can MDMA can help people feel safe, in order to work through and heal trauma “We are all the products of our attachment relationships.” - Ben Breaking Convention This past year was the 5th one There were 1300 attendees from all over the world What's wonderful about Breaking Convention is how multidisciplinary it is There's the guy in the gray suit in one room talking about high level neuroscience and a hippie with dreads in the other room talking about the spirits that live in the Salvia leaves Ben says they work really hard to make that balance work There's a lot of debate and conflict in the psychedelic movement right now, Breaking Convention is very important for creating space for this debate Looking ahead Ben is looking into opening a clinic He mentions academia is not his area of study, he is a clinician, but this research is an excuse to treat patients Links Breaking Convention About Ben Sessa Ben Sessa is a consultant psychiatrist in adult addictions, working part-time at Addaction in Weston-Super-Mare and is senior research fellow at Bristol, Cardiff and Imperial College London Universities, where he is currently taking time off clinical medical practice to study towards a PhD in MDMA Psychotherapy. He has specialist training as a child and adolescent psychiatrist and is interested in the developmental trajectory from child maltreatment to adult mental health disorders. Dr Sessa’s joint interests in psychotherapy, pharmacology and trauma have lead him towards researching the subject of drug-assisted psychotherapy using psychedelic adjuncts. He is the author of two books exploring psychedelic medicine; The Psychedelic Renaissance (2012) and To Fathom Hell or Soar Angelic (2015) and is currently conducting research with Imperial College London and Cardiff universities studying the potential role for MDMA-assisted therapy for the treatment of PTSD and alcohol dependence syndrome. Dr Sessa is outspoken on lobbying for change in the current system by which drugs are classified in the UK, believing a more progressive policy of regulation would reduce the harms of recreational drug use. He is a co-founder and director of the UK’s Breaking Convention conference.

We open the show with the victory speech from Daniel Andrews (ALP MP), leader of the Labor Party in Victoria and winner of the 2018 state election.Nick and Ash discuss the week in drug news, with special consideration for the previous day's election.SEGMENT2017's Entheogenesis Australis (EGA) Psychedelic Symposium featured a wide range of speakers, including Dr. Ben Sessa, who's talk is hear on this show.Dr Ben Sessa (MBBS BSc MRCPsych) is a consultant child and adolescent psychiatrist working in adult addiction services and with custodial detained young people in a secure adolescent setting. He trained at UCL medical school, graduating in 1997. He is interested in the developmental trajectory from child maltreatment to adult mental health disorders. Dr Sessa is currently a senior research fellow at Bristol, Cardiff and Imperial College London Universities, where he is conducting the UK's first clinical studies with MDMA-assisted therapy for the treatment of PTSD and alcohol dependence syndrome. In the last ten years, he has worked on several UK-based human pharmacology trials as study doctor or as a healthy subject administering and receiving test doses of LSD, psilocybin, MDMA and ketamine. He is the author of several dozen peer-reviewed articles in the mainstream medical press and has written two books exploring psychedelic medicine; The Psychedelic Renaissance (2012) and To Fathom Hell or Soar Angelic (2015). In speaking publicly at universities and medical conferences, Dr Sessa is outspoken on lobbying for change in the current system by which drugs are classified in the UK, believing a more progressive policy of regulation would reduce the harms of recreational drug use and provide increased opportunities for clinical psychedelic research. He is a co-founder and director of the UK's Breaking Convention conference.

Dr. Ben Sessa is a psychiatrist from the United Kingdom, and currently a senior research fellow at Bristol, Cardiff and Imperial College London Universities, where he is conducting the UK's first clinical studies with MDMA-assisted therapy for the treatment of PTSD and alcohol dependence syndrome. Ben and I spoke at length about the current state of psychedelic psychotherapy, exploring topics such as success rates for clients, how to work with trauma in a psychedelic state, whether depression is in fact treatable by this method, ego loss, shedding negative personal narratives, and much more. He is a stupendous voice of reason and is very much poised on the cutting edge of clinical research in regards to the sanctioned use of psychedelics for healing.

Download Dr. Ben Sessa is a writer, psychiatrist, and researcher working in the UK to start the first ever MDMA for alcohol addiction study. We have a very exciting discussion and even get Dr. Sessa's first reaction to the idea of DMTx. We also explore Ben's background and his experiences with psychedelics legally - Ben is one of the few people who has ever received MDMA, LSD, DMT, ketamine, and psilocybin in a legal research setting. We hope you enjoy this episode! Leave a comment below and let us know what you think. Links Ben Sessa's website - Mandala Therapy Limited  BBC Three - Druglands Towards an Integration of Psychotherapy and Pharmacology: Using psychedelic drug-assisted psychotherapy by Dr. Ben Sessa  Breaking Convention conference - London Facebook - https://www.facebook.com/BreakingConvention/  Twitter - https://twitter.com/drsessa Books The Psychedelic Renaissance           To Fathom Hell or Soar Angelic The Psychedelic Renaissance Psychedelic Drug Treatments           Dr. Ben Sessa - Videos https://vimeo.com/38063005 https://www.youtube.com/watch?v=UygZnBTWW0M About Ben Sessa Dr. Ben Sessa, M.B.B.S., M.D., B.Sc., M.R.C.Psych., is a consultant child and adolescent psychiatrist working in adult addiction services and with custodial detained young people in a secure adolescent setting. He trained at UCL medical school, graduating in 1997. He is interested in the developmental trajectory from child maltreatment to adult mental health disorders. Dr Sessa is currently a senior research fellow at Bristol, Cardiff and Imperial College London Universities, where he is conducting the UK's first clinical studies with MDMA-assisted therapy for the treatment of PTSD and alcohol dependence syndrome. In the last ten years he has worked on several UK-based human pharmacology trials as study doctor or as a healthy subject administering and receiving test doses of LSD, psilocybin, MDMA, DMT, and ketamine. He is the author of several dozen peer-reviewed articles in the mainstream medical press and has written two books exploring psychedelic medicine; The Psychedelic Renaissance (2012 and 2017) and To Fathom Hell or Soar Angelic (2015). In speaking publicly at universities and medical conferences, Dr Sessa is outspoken on lobbying for change in the current system by which drugs are classified in the UK, believing a more progressive policy of regulation would reduce the harms of recreational drug use and provide increased opportunities for clinical psychedelic research. He is a co-founder and director of the UK's Breaking Convention conference.   Enter to win a bunch of product from Bluebird Botanicals!!

Broadcast live from the Entheogenesis Australis (EGA) 2017 Psychedelic Symposium at Holmesglen in Eildon.Hosted by Nick WallisWith blanket bans on psychoactives increasing, cognitive liberty is in chains. Where does reform for laws covering psychedelics fit within drug law reform? In an environment where evidence is not the drive for policy how do we keep policy makers accountable? What have we learned recent work and development? How can you help with the next steps? A number of individuals who have been involved with drug law and policy activism will join a panel to discuss strategies for reform.The panel will bring along some recent examples of activism and workshop these with the audience, drawing out successful strategies, unsuccessful strategies and discussing potential future campaigns.PANELRICK DOBLINIn the mid 1970s MDMA, then known as Adam was used quietly in psychotherapy. In the 1980s, growing recreational use of Ecstasy led to the criminalization of the drug and the formation of MAPS in 1986. Now, MAPS is about to embark on FDA-approved Phase 3 research to make MDMA-assisted psychotherapy a legal treatment for PTSD. This talk will discuss the historical implications of MDMA use and the plans for ongoing clinical research.Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard's Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master's thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary's Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and one of three children (two in college).MONICA BARRATTDR MONICA BARRATT is a social scientist at the Drug Policy Modelling Program, part of Australia's National Drug and Alcohol Research Centre at the University of New South Wales. Monica's work examines the social and public health implications of digital technologies for people who use illicit and emerging psychoactive drugs. Research topics emerging from this interest include online drug markets or cryptomarkets and policy responses to novel psychoactive substance evolution. She specialises in engaging hard-to-reach networks and groups in digital spaces in conversations about research and policy, to inform policy change. Monica also serves as an Editor for policy-related articles at the International Journal of Drug Policy, and as the Director of Research at the international drug harm reduction community Bluelight.org. Monica is a lead researcher for the Global Drug Survey. She is also a regular attendee and contributor to EGA, from the mid-2000s.NICK KENTNICK KENT works as a secondary school teacher in the areas of languages and the humanities. He is currently completing his Masters through research at the Melbourne Graduate School of Education, where he is undertaking a critical discourse analysis of school policies and resources as they relate to drug education, comparing both local and international examples. After completing the Grad. Dip in Teaching in 2015, Nick was perplexed at the lack of teacher training around student drug use and the silence of the education system on this issue, as well as the slow pace of drug reform more broadly. Inspired to learn more, and to advocate and research this area further, Nick helped found Students for Sensible Drug Policy Australia in 2016, setting up their second chapter at the University of Melbourne. Nick was instrumental in the UniMelb chapter's work in setting up a harm reduction program that would supply re-agent drug checking kits to students free of charge through the Student Union, and has travelled to numerous international conferences to represent this globally significant program. Nick draws upon his experience in nightclub and festival communities, as well as his experience volunteering with DanceWize as a Peer Educator and his policy and international experience with SSDP in both his teaching and his research.FIONA MEASHAMFiona Measham is co-founder & co-Director of ‘The Loop’. The Loop conducts forensic testing of drugs at UK festivals and nightclubs and provides associated welfare support. Fiona Measham was appointed Professor of Criminology in the School of Applied Social Sciences at Durham University in 2012. Fiona has conducted research for over two decades across a broad area of criminology and social policy, exploring changing trends in legal and illegal drugs; the night time economy and the socio-cultural context to consumption; gender; the regulation and policing of intoxication; electronic music scenes and club cultures; issues of deterrence, displacement and desistance; and broader policy implications. A key feature of her research has been the development of in-situmethods of data collection in pubs, clubs and festivals, a working environment with which she is familiar, having spent her early adulthood working in bars and clubs across several continents in various guises.BEN SESSADR BEN SESSA (MBBS BSc MRCPsych) is a consultant child and adolescent psychiatrist working in adult addiction services and with custodial detained young people in a secure adolescent setting. He trained at UCL medical school, graduating in 1997. He is interested in the developmental trajectory from child maltreatment to adult mental health disorders. Dr Sessa is currently a senior research fellow at Bristol, Cardiff and Imperial College London Universities, where he is conducting the UK's first clinical studies with MDMA-assisted therapy for the treatment of PTSD and alcohol dependence syndrome. In the last ten years he has worked on several UK-based human pharmacology trials as study doctor or as a healthy subject administering and receiving test doses of LSD, psilocybin, MDMA and ketamine. He is the author of several dozen peer-reviewed articles in the mainstream medical press and has written two books exploring psychedelic medicine; The Psychedelic Renaissance (2012) and To Fathom Hell or Soar Angelic (2015). In speaking publicly at universities and medical conferences, Dr Sessa is outspoken on lobbying for change in the current system by which drugs are classified in the UK, believing a more progressive policy of regulation would reduce the harms of recreational drug use and provide increased opportunities for clinical psychedelic research. He is a co-founder and director of the UK's Breaking Convention conference.

Nick and Ash discuss the week in drug news.SEGMENT(TWO PART - PART ONE) Dean Wright and Melissa Warner from the Australian Psychedelic Society are at the 2017 Psychedelic Science conference in Oakland California. At the conference, they caught up with Dr. Ben Sessa, a consultant child and adolescent psychiatrist working in adult addiction and senior research fellow at Bristol, Cardiff and Imperial College London Universities, where he is currently taking time off clinical medical practice to study towards a PhD in MDMA Psychotherapy.Dr. Ben Sessa is one of the speakers at December's Entheogenesis Australis - EGA psychedelic symposium. Tickets are on sale now at http://www.entheogenesis.org/ticketsMUSICWhitebear - Inanimate IncarnateSEGMENT(TWO PART - PART TWO) Dean Wright and Melissa Warner from the Australian Psychedelic Society are at the 2017 Psychedelic Science conference in Oakland California. At the conference, they caught up with Dr. Ben Sessa, a consultant child and adolescent psychiatrist working in adult addiction and senior research fellow at Bristol, Cardiff and Imperial College London Universities, where he is currently taking time off clinical medical practice to study towards a PhD in MDMA Psychotherapy.Dr. Ben Sessa is one of the speakers at December's Entheogenesis Australis - EGA psychedelic symposium. Tickets are on sale now at http://www.entheogenesis.org/tickets

Get FULL program Notes at: www.PsychedelicParenting.org/?p=1396 Dr. Ben Sessa is a consultant in adult addictions and is senior research fellow at Bristol, Cardiff and Imperial College London Universities, where he is currently taking time off from clinical medical practice to study towards a PhD in MDMA Psychotherapy, and has specialist training as a child and adolescent psychiatrist. Dr Sessa's joint interests in psychotherapy, pharmacology and trauma have lead him towards researching the subject of drug-assisted psychotherapy using psychedelic adjuncts. In this conversation, Jonathan and Ben discuss "How old is old enough," the illogic of the new UK Psychoactive Substances Law, and how to take your kids to festivals safely. Ben also explains his belief in why the medical model of psychedelics has the best chance of changing the hearts and minds of mainstream culture and making them more widely available to all. As a pediatric psychiatrist, a father of 2, and an expert in the clinical application of psychedelic medicines, Dr. Sessa is uniquely qualified to provide insight into many of the questions we often ask here at Psychedelic Parenting, and we are excited to have him on the show.